PRIMECAP Management
Add transactions in Novartis AG Common Stock $NVS and Septerna, Inc. $SEPN.
Obesity, diabetes, GLP-1, and metabolic disease exposure. This page tracks 226 investor, Congress, and insider actions tied to GLP-1 & Metabolic Health within Healthcare Innovation, connecting the industry classification with the people and institutions currently showing activity. It gives context from 148 gurus across 170 stocks, so the feed can be read as an industry-level signal rather than a loose list of single-stock events.
Add transactions in Novartis AG Common Stock $NVS and Septerna, Inc. $SEPN.
Buy $45.3K of disclosed value in ProMIS Neurosciences, Inc. $PMN.
Trim transactions in TransMedics Group, Inc. $TMDX and Insulet Corp $PODD.
Sell $30.9K of disclosed value in BeOne Medicines Ltd. $ONC.
Trim transactions in Eli Lilly and Co $LLY and Novo Nordisk A/S $NVO.
Buy $31.4K of disclosed value in Altimmune, Inc. $ALT.
Trim $-340.6M of disclosed value in Eli Lilly and Co $LLY.
Sell $35.8K of disclosed value in LifeStance Health Group, Inc. $LFST.
Trim $105.5M of disclosed value in Novo Nordisk A/S $NVO.
Exit $-301.6M of disclosed value in iRhythm Technologies, Inc. $IRTC.
Add $2.1B of disclosed value in Novartis AG Common Stock $NVS.
Add $103.2M of disclosed value in Pharvaris N.V. $PHVS.
Add $10.9M of disclosed value in Novartis AG Common Stock $NVS.
Add $7.7M of disclosed value in Eli Lilly and Co $LLY.
Add $28.7M of disclosed value in PTC THERAPEUTICS, INC. $PTCT.

Trim $66.0M of disclosed value in Eli Lilly and Company Common Stock $LLY.